Tinzaparin as an antithrombotic: an overview

Hosp Med. 1998 Feb;59(2):145-8.


Tinzaparin is a low molecular weight heparin which is given subcutaneously once daily without the need for laboratory monitoring. Already established as effective therapy for deep venous thrombosis, in November 1997 it became the first low molecular weight heparin to be licensed for the treatment of pulmonary embolism.

MeSH terms

  • Fibrinolytic Agents / pharmacology
  • Fibrinolytic Agents / therapeutic use*
  • Heparin, Low-Molecular-Weight / pharmacology
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Injections, Subcutaneous
  • Pulmonary Embolism / drug therapy*
  • Thrombophlebitis / drug therapy*
  • Tinzaparin


  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight
  • Tinzaparin